VIDAS® B•R•A•H•M•S PCT™
PCT-guided antibiotic therapy.
The supplier does not provide quotations for this product through SelectScience. You can search for similar products in our Product Directory.
More labor intensive than I would prefer.
Perform PCT testing in a stat lab
The PCT assay has been a reliable platform for our lab, the QC is consistent. The only down fall is the maunal loading of sample. More automation would be beneficial in a larger lab
Review Date: 18 Apr 2023 | bioMérieux USA
VIDAS B•R•A•H•M•S PCT aids physicians in making rational clinical decisions and allows optimized patient management. Results are available in only 20 minutes.
Procalcitonin (PCT) helps differentiate bacterial from viral infections, the early detection of an elevated PCT level in patients with suspected bacterial infections enabling earlier antibiotic treatment. PCT also supports informed decisions on when to continue or stop antibiotics, improving patient care and decreasing antibiotic misuse and resistance.
PCT has been demonstrated to aid in the following:
- Assess initial risk of sepsis
- Monitor patient progress and mortality risk during treatment for sepsis
- Determine whether to start antibiotics for Lower Respiratory Tract Infection (LRTI)
- Determine when to discontinue antibiotics
Linking antimicrobial resistance & sepsis: A value-based approach
In this webinar, Dr. Mark Miller, Executive Vice President and Chief Medical Officer at bioMérieux, will discuss the major global healthcare issue that is sepsis. He will cover topics such as the effectiveness of sepsis ‘bundles’, the value of leveraging diagnostics for prognosis, organ failure determination, antibiotic stewardship, immune monitoring, and risk of acute kidney injury. The significant role that antimicrobial resistance plays in sepsis patients will also be explored.
This webinar is available to receive 0.5 P.A.C.E. Contact Hours via bioMérieux University
Rapid diagnostics combat unnecessary antimicrobial use in pulmonary disease management
Discover how a rapid diagnosis between viral and bacterial pulmonary infections can minimize antibiotic usage in critical care
bioMérieux announces CE-marking of VIDAS KUBE, the next generation system in the VIDAS immunoassay portfolio
The latest addition to this innovative range combines advanced technology with the recognized values of the VIDAS solution
